1601 - 1610 of 8666 Results
Title
Year
-
OPENTitle: QRATER: a collaborative and centralized imaging quality control web-based applicationJournal Name: Aperture NeuroPublisher: Organization for Human Brain MappingVol: 4Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.52294/001c.118616Best OA location URL: https://doi.org/10.52294/001c.118616Citation Count: 1
- Bioinformatics pipeline to guide post‐GWAS studies in Alzheimer's: A new catalogue of disease candidate short structural variants2023RESTRICTEDTitle: Bioinformatics pipeline to guide post‐GWAS studies in Alzheimer's: A new catalogue of disease candidate short structural variantsJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 9Start Page: 4094End Page: 4109Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.13168Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10524333/pdf/nihms-1901812.pdfCitation Count: 1
- Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease2023OPENTitle: Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 115Issue #:Start Page: 105822End Page: 105822Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105822Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10853986/pdf/nihms-1931898.pdfCitation Count: 3
- Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromine2024OPENTitle: Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107158End Page: 107158Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107158Best OA location URL: https://doi.org/10.1016/j.parkreldis.2024.107158Citation Count: 2
-
OPENTitle: Long-term trajectories of ambulatory impairment in multiple sclerosisJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 29Issue #: 10Start Page: 1282End Page: 1295Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/13524585231187521Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10528275/pdf/nihms-1912749.pdfCitation Count: 6
- Differential Cognitive Effects of Unilateral Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease2024OPENTitle: Differential Cognitive Effects of Unilateral Subthalamic Nucleus Deep Brain Stimulation for Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 95Issue #: 6Start Page: 1205End Page: 1219Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26903Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26903Citation Count: 17
-
OPENTitle: Florbetaben amyloid PET acquisition time: Influence on Centiloids and interpretationJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 8Start Page: 5299End Page: 5310Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.13893Best OA location URL: https://doi.org/10.1002/alz.13893Citation Count: 5
- Profiling people with Parkinson's disease at risk of cognitive decline: Insights from PPMI and ICICLE‐PD data2024OPENTitle: Profiling people with Parkinson's disease at risk of cognitive decline: Insights from PPMI and ICICLE‐PD dataJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 16Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1002/dad2.12625Best OA location URL: https://doi.org/10.1002/dad2.12625Citation Count: 7
- A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease2023OPENTitle: A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1493End Page: 1502Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29450Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29450Citation Count: 25
- Reply to: Comment on “Summing MDS‐UPDRS Parts 1 + 2 (Non‐motor and Motor Experience of Daily Living): The Patient's Voice”2023OPENTitle: Reply to: Comment on “Summing MDS‐UPDRS Parts 1 + 2 (Non‐motor and Motor Experience of Daily Living): The Patient's Voice”Journal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1564End Page: 1564Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29513Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10652225/pdf/nihms-1940156.pdfCitation Count: 0